Partial Superficial, Superficial, and Total Parotidectomy in the Management of Benign Parotid Gland Tumors: A 10-Year Prospective Study of 205 Patients

Stathopoulos, Panagiotis; Igoumenakis, Dimosthenis; Smith, William P.

doi:10.1016/j.joms.2017.06.018

Cited by 43 publications

(32 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Wound infection was reported in 94 studies 6,9,12,14,15,17,21–25,27,28,31,35,36,39–44,49,55,57–67,69–72,74,75,79,81,85–90,92,93,95,96,98–103,105–107,111,112,115–122,124,125,128,131–149 reporting on 15,861 patients (Table I and Fig. 2B).…”

Section: Resultsmentioning

confidence: 95%

Minor Parotidectomy Complications: A Systematic Review

et al. 2020

View full text Add to dashboard Cite

Objectives To report descriptive statistics for minor parotidectomy complications. Methods A systematic review was performed, selecting 235 studies for analysis. The incidence of complications was tabulated, and descriptive statistics calculated. Outlier studies, 1 standard deviation above the mean, were reexamined to determine potential causal factors for each complication. All studies were examined for statistically significant differences for any potential causal factor. Results The pooled incidence of minor complications reported were hematoma 2.9% (95% confidence interval [CI]: 2.4‐3.5), wound infection 2.3% (95% CI: 1.8‐2.9), sialocele 4.5% (95% CI: 3.5‐5.7), salivary fistula 3.1% (95% CI: 2.6‐3.7), flap necrosis 1.7% (95% CI: 1.1‐2.5), scar issues 3.6% (95% CI: 2.4‐5.4), numbness 33.9% (95% CI: 25.6‐43.4), and deformity 11.8 (95% CI: 6.9‐19.5). Implants result in more wound complications, such as hematoma, sialocele, or salivary fistula. Sialocele and salivary fistula appear more frequently after less extensive parotid surgery, whereas hematoma, wound infections, flap necrosis, and aesthetic considerations are worse with more extensive resections. Conclusions Minor parotidectomy complications are more frequent than generally assumed and related to certain factors that should be investigated. Laryngoscope, 131:571–579, 2021

show abstract

Section: Resultsmentioning

confidence: 95%

Minor Parotidectomy Complications: A Systematic Review

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Transient facial nerve palsy is significantly less frequent after partial superficial parotidectomy (9.6%) than after total (40%) and superficial parotidectomy (28%). 9…”

Section: Partial Superficial Parotidectomy (Pp) To Treat Benign Parotmentioning

confidence: 99%

Conservative and functional surgery in the treatment of salivary gland tumours

Peng

2019

Int J Oral Sci

View full text Add to dashboard Cite

The principle of modern oncological surgery is to conserve the functional organs or tissues as much as possible based on eradication of the tumour. For salivary gland tumours, conservative and functional salivary surgery, including partial sialoadenectomy as well as anatomical and functional preservation of the facial nerve, great auricular nerve, superficial musculo-aponeurotic system (SMAS), and Stensen’s duct, has become increasingly popular. In the present review, we discuss the following aspects of conservative and functional surgery in the treatment of salivary gland tumours: (i) partial superficial parotidectomy (PP) to treat benign parotid gland tumours, (ii) modification of surgical incisions to improve cosmetic results, (iii) modification of the surgical approach to decrease complications, (iv) extracardial dissection to treat benign superficial parotid tumours, (v) partial sialoadenectomy to treat benign submandibular gland tumours, and (vi) 125I brachytherapy to preserve facial nerves. The majority of the operated parotid or submandibular glands are preserved, and surgical complications are also decreased. Conservative and functional surgery plays a significant role in maintaining normal salivary gland function and in improving patients’ quality of life during the treatment of salivary gland tumours and thus should be further promoted.

show abstract

“…Furthermore, much higher rates of facial nerve paresis were observed for revision parotid surgery [16, 22, 23], wide extent of surgery (total parotidectomy) [15, 16, 22–26], tumor located deeper than the facial nerve plane [17, 27], and in cases with large tumors [25, 28–30]. Recent studies also reported the improved rates of functional facial nerve preservation in parotidectomy, with the aid of preoperative imaging tests, intraoperative monitoring of the facial nerve, or surgical magnification [31–36]. Still there have been no strong evidence to support the preventive role of intra-operative facial nerve monitoring from facial nerve injury during parotidectomy.…”

Section: Introductionmentioning

confidence: 99%

Incidence of postoperative facial weakness in parotid tumor surgery: a tumor subsite analysis of 794 parotidectomies

Jin¹,

Kim²,

Kim³

et al. 2019

BMC Surg

View full text Add to dashboard Cite

BackgroundThe reported incidence of facial weakness immediately after parotid tumor surgery ranges from 14 to 65%. The purpose of this study was to evaluate the incidence of postoperative facial weakness related to parotidectomy with use of preoperative computed tomography (CT), intraoperative facial nerve monitoring, and surgical magnification. Also, we sought to elucidate additional information about risk factors for postoperative facial weakness in parotid tumor surgery, particularly focusing on the tumor subsites.MethodsWe retrospectively reviewed 794 cases with parotidectomy for benign and malignant tumors arising from the parotid gland (2009–2016). Patients with pretreatment facial palsy were excluded from the analyses. Tumor subsites were stratified based on their anatomical relations to the facial nerve as superficial, deep, or both. Multivariable logistic regression analyses were conducted to identify risk factors for postoperative facial weakness.ResultsThe overall incidences of temporary and permanent (more than 6 months) facial weakness were 9.2 and 5.2% in our series utilizing preoperative CT, intraoperative facial nerve monitoring, and surgical magnification. Multivariable analysis revealed that old age, malignancy, and recurrent tumors (revision surgery) were common independent risk factors for both temporary and permanent postoperative facial weakness. In addition, tumor subsite (tumors involving superficial and deep lobe) was associated with postoperative facial weakness, but not tumor size. Extent of surgery was strongly correlated with tumor pathology (malignant tumors) and tumor subsite (tumors involving deep lobe).ConclusionAside from risk factors for facial weakness in parotid tumor surgery such as old age, malignant, or recurrent tumors, the location of tumors was found to be related to postoperative facial weakness. This study result may provide background data in a future prospective study and up-to-date information for patient counseling.

show abstract

Partial Superficial, Superficial, and Total Parotidectomy in the Management of Benign Parotid Gland Tumors: A 10-Year Prospective Study of 205 Patients

Cited by 43 publications

References 21 publications

Minor Parotidectomy Complications: A Systematic Review

Minor Parotidectomy Complications: A Systematic Review

Conservative and functional surgery in the treatment of salivary gland tumours

Incidence of postoperative facial weakness in parotid tumor surgery: a tumor subsite analysis of 794 parotidectomies

Contact Info

Product

Resources

About